3Ma~n B,Rem6n C,P&ez-Fonthn M,et al.Benefits of preserving residual renal function in peritoneal dialysis[J].Kidney Int Suppl,2008,10(8):$42-$51.
4Brener ZZ,Thijssen S,Kotanko P, et al.The impact of residual renal function on hospitalization and mortality in incident hemodialysis patients[J].Blood Purif2011,31 (4):243-251.
5Penne EL,ven der Weerd NC,Grooteman MP, et al.Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients[J].Clin J Am Soc Nephrol,2011,6(2):281-289.
2Michael Allon,John Daugirdas,Thomas A,et al. Effect ofchange in v.ascular access on patient mortality in hemodial- ysis patients[J]. American Journal of Kidney Diseases, 2006,47 (3) : 469-477.
3Paul M Ridker, Nader Rifai, Lowenthai SP, et al. Rapid re- duction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia[J]. Circulation: Journal of the American Heart Association,2001,103(27) :.
4Antonio M, Gotto. Role of C-reactive protein in coronary risk reduction:Focus on primary prevention[J]. The Amer- ican Journal of Cardiology, 2013,8 (5) : 31-33.
5Peter Stenvinkel, Roberto Pecoits-Filho, Bengt Lindholm. Gene polymorphism association studies in dialysis:The nutrition-inflammation axis[J]. Seminars in Dialysis,2014, 9(4):16-19.
6Harry Yu,Nader Rifai. High-sensitivity C-reactive pro- tein and atherosclerosis:From theory to therapy[J]. Clinical Biochemistry, 2012,3 (8) : 87-89.
7A Meguid E1 Nahas,Aminu K Bello. Chronic kidney dis- ease:The global challenge[J]. The Lancet,2014,6(7): 95-98.
8Wolfgang Koenig. Inflammation and coronary heart dis- ease : An overview[J]. Cardiology in Review, 2012,7 ( 1 ) : 44-46.
